Table of Contents Table of Contents
Previous Page  755 / 916 Next Page
Information
Show Menu
Previous Page 755 / 916 Next Page
Page Background

25th European Congress of Psychiatry / European Psychiatry 41S (2017) S710–S771

S751

eosinophilia have been described. This work describes a case of

transient eosinophilia caused by clozapine.

Methods

Description of a clinical case.

Results

A 22-year-old female patient, with a treatment resistant

psychotic disorder initiated clozapine in a slow titration to 300mg.

Ten days after initiating clozapine, the patient presented with

eosinophilia (started with 6.6

×

108/L and peaked at 10.0

×

108/L).

Two weeks later, the patient presented with a skin rash in the arms

and legs. The casewas discussedwith internal medicine service and

other causes of eosinophilia were excluded. Since the eosinophilia

was mild, the rash was not severe and the patient did not present

any other symptoms or signs, it was not considered necessary to

stop clozapine. During the next three months, with close monitor-

ing, the eosinophilia and the skin rash slowly resolved.

Conclusions

This is a case of a patient who presented mild

eosinophilia and skin rash, associated to clozapine, with spon-

taneous resolution. We draw attention to the need of close

monitorization and exclusion of other causes of eosiniphilia

and rash. Furthermore, other hematologic disorders should be

considered besides agranulocytosis, namely eosinophilia, when

prescribing clozapine.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.1396

EV1067

Polycystic ovarian syndrome in

patients with schizophrenia treated

with atypical anti-psychotics: A case

control study

V. De Silva

1 ,

, A. Senanayake

1

, S.S. Ratnatunga

2

, S. Dissanayake

1

,

S. Gamage

1

, S. De Silva

1

, R. Hanwella

1

, C. Wijeyaratne

1

1

Faculty of Medicine, University of Colombo, Psychiatry, Colombo, Sri

Lanka

2

NHSL, Psychiatry, Colombo, Sri Lanka

Corresponding author.

Objective

Objective was to compare the prevalence of probable

polycystic ovarian syndrome (PCOS) in females treated with atyp-

ical anti-psychotics with normal controls.

Aims

To compare the prevalence of PCOS in patients treated with

atypical anti-psychotics and normal controls. To study the hormone

profiles in these two groups.

Methods

Cases consisted of 102 reproductive age females with

schizophrenia treated with atypical anti-psychotics for

6months

and had gained

10% body weight. Control group was 123 age and

BMI matched females. Menstrual history, physical examination for

hirsuitism, acne, androgenic alopecia, anthropometrics measures,

Ultrasound abdomen and hormone analysis were done.

Results

Mean age of cases = 33.17 years (SD 8.9) and con-

trols = 33.08 years (SD 5.6). Mean BMI of cases = 25.92 (SD 5.2) and

controls = 25.03 (SD 4.3). Polycystic ovarian morphology of ovaries

on ultra sound scan was significantly more in cases 49 (48%) than

controls 16 (13.%) (

P

< 0.001). Probable PCOS was significantlymore

in atypical anti-psychotic treated females (

n

= 22, 21.56%) than in

normal controls (

n

= 10, 8.13%) (

P

= 0.04). Atypical anti-psychotic

treated patients with PCOS had significantly lower mean LH levels

6.69mIU/L than those without PCOS 10.30 (

P

= 0.35). There was no

significant difference in testosterone, FSH, prolactin, TSH and free

T4 levels.

Conclusion

Treatment with atypical anti-psychotics is associated

with higher prevalence of PCOS. This has not been reported previ-

ously. The hormonal profile in these patients may be different with

low testosterone and LH levels.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.1397

EV1068

Unconventional side effects of

antidepressants: Focus on emotional

blunting

V. Falaschi

1 ,

, S. Baroni

1

, F. Mucci

1

, H. Akiskal

2

, D. Marazziti

1

1

Università di Pisa, Dipartimento di Medicina Clinica e Sperimentale,

Pisa, Italy

2

University of California, Department of Psychiatry, San Diego, USA

Corresponding author.

Objectives

The aimof this studywas to investigate the unconven-

tional side-effects of selective serotonin reuptake inhibitors (SSRIs)

and tricyclics (TCAs) antidepressants during long-term treatment

of depression, with a special focus on emotional blunting and, in

particular, on the possible changes of some features of loving rela-

tionships.

Methods

Two hundred outpatients (130 women and 70 men,

mean age

±

SD: 43.4

±

11.1 years) were enrolled. They were suffer-

ing frommild or moderate depression, according to DSM–5 criteria,

treatedwithone antidepressant for at least sixmonths and involved

in a long-term loving relationship. A specifically designed test, the

so-called “sex, attachment, love” (SALT) questionnaire was built to

assess the possible changes of the loving relationship.

Results

The results showed differences between the two genders,

in particular women taking TCAs reported more sexual side effects

thanmen, whereas men taking SSRIs complained a reduction of the

feelings of love and attachment towards the partner.

Conclusions

Antidepressants seem to have a dimorphic effect on

some elements of loving relationships, however these results need

to be further explored.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.1398

EV1069

Citalopram–induced delusions in an

older adult

J. Fennema

1 ,

, S . P

etrykiv

2 , L. D

e Jonge

3 , M.

Arts

4

1

GGZ Friesland, Geriatric Psychiatry, Leeuwarden, The Netherlands

2

University of Groningen, University Medical Center Groningen,

Department of Clinical Pharmacy and Pharmacology, Groningen, The

Netherlands

3

Leonardo Scientific Research Institute, Department of Geriatric

Psychiatry, Groningen, The Netherlands

4

University of Groningen, University Medical Center Groningen,

Department of Old Age Psychiatry, Groningen, The Netherlands

Corresponding author.

Introduction

Selective serotonin reuptake inhibitors (SSRIs) are

the most prescribed antidepressants worldwide. In older adults,

citalopram is generally well tolerated and safe in the therapeutic

dose range of 20 to 40mg/day. In literature, there are cases of SSRI-

induced psychosis, but mainly with fluoxetine. There are only three

reported cases of citalopram-induced delusions, however, these

case-reports did not involve an older adult.

Objectives and aims

To provide a case of citalopram–induced

psychosis in an older adult, followed by the review of available

literature.

Methods

A case report is presented and discussed followed by a

literature review.

Results

A 64-year-old woman without somatic illnesses was

referred by a general practitioner with depressive symptoms. One

week after initiation of citalopram 10mg/day she suddenly devel-

oped delusions, predominantly in the early morning. No other

medical evidence was found that could explain her delusions. After

discontinuation of citalopram her delusions quickly resolved.

Conclusion

This is the first case report of a SSRI-induced delu-

sion in an older adult. Citalopram has been reported to be one of